Radiotherapy for Incidental Adenocarcinoma of the Prostate

  • I. D. Kaplan
  • M. A. Bagshaw
  • C. A. Cox
  • R. S. Cox


Carcinoma is often discovered in the tissue removed at transurethral resection for urinary obstruction (TURP). Newman and associates report incidental carcinoma in 14% of TURP specimens with careful pathologic evaluation [1]. The high incidence of prostatic cancer found at TURP or autopsy and a much lower age-adjusted mortality from this disease imply that incidental carcinoma is often clinically unimportant. However, these patients are a very heterogeneous group; some never experience disease progression, and others exhibit a significant incidence of lymph node involvement and die of metastatic disease irrespective of local treatment.


Radical Prostatectomy Gleason Score Diffuse Involvement Prostatic Cancer Stage Incidental Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Newman AJ Jr, Graham MA, Carlton CE Jr, Lieman S (1982) Incidental carcinoma of the prostate at the time of transurethral resection importance of evaluating every chip. J Urol 128:948PubMedGoogle Scholar
  2. 2.
    Gleason DF and the Veterans Administration Cooperative Urological Research Group (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, pp 171–197Google Scholar
  3. 3.
    Donohue RE, Muni JH, Whitesel JA, Mohr S, Scanavino D, Augspurger RD, Biber RJ, Fauver HE, Wettlauter JN, Pfister RR (1982) Pelvic lymph node dissection: guide to patient management in clinically locally confined adenocarcinoma of the prostate. Urology 20:559–565PubMedCrossRefGoogle Scholar
  4. 4.
    Whitmore WF Jr (1973) The natural history of prostatic cancer. Cancer 32:1104–1112PubMedCrossRefGoogle Scholar
  5. 5.
    Brawn PN (1983) The dedifferentiation of prostate carcinoma. Cancer 52:246–251PubMedCrossRefGoogle Scholar
  6. 6.
    Bagshaw MA (1986) Current conflicts in the management of prostatic cancer. Int J Radiat Oncol Biol Phys 12:1721–1727PubMedCrossRefGoogle Scholar
  7. 7.
    McNeal JE (1969) Origin and development of carcinoma in the prostate. Cancer 23:24–34PubMedCrossRefGoogle Scholar
  8. 8.
    Epstein JI, Pauli G, Eggleston JC, Walsh PC (1986) Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow-up. J Urol 136:837–839PubMedGoogle Scholar
  9. 9.
    Lowe BA, Listrom MB (1988) Incidental carcinoma of the prostate: an analysis of the predictors of progression. J Urol 140:1340–1344PubMedGoogle Scholar
  10. 10.
    Pistenma DA, Bagshaw MA, Freiha FS (1979) Extended field radiation therapy for prostatic adenocarcinoma. Status report of a limited prospective trial. In: Johnson PE, Samuels ML (eds) Cancer of the genitourinary tract. Raven, New York, pp 229–248Google Scholar
  11. 11.
    Beynon LL, Busuttil A, Newsam JE, Chisholm GD (1983) Incidental carcinoma of the prostate: selection for deferred treatment. Br J Urol 55:733–736PubMedCrossRefGoogle Scholar
  12. 12.
    Barnes R, Hirst A, Rosenquist K (1976) Early carcinoma of the prostate: comparison of stage A and B. J Urol 115:404PubMedGoogle Scholar
  13. 13.
    Beathers OH, Meyers MH (eds) (1988) Manual for staging cancer. Lippincott, PhiladelphiaGoogle Scholar
  14. 14.
    McMillen SM, Wettlaufer JV (1976) The role of repeat transurethral biopsy in stage A carcinoma of the prostate. J Urol 116:759–760PubMedGoogle Scholar
  15. 15.
    Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergstrom, R, Kraaz W (1989) Natural history of localized prostatic cancer: a population-based study in 223 untreated patients. Lancet 8642:799–803CrossRefGoogle Scholar
  16. 16.
    Madsen PO, Graversen PH, Gasser TL, Corle DK (1988) Treatment of localized cancer. Radical prostatectomy versus placebo. A 15 year follow-up. Scand J Urol Nephrol (Suppl) 110:95–100Google Scholar
  17. 17.
    Prout GP, Heaney JA, Griffin PP, Daly JJ, Shipley WV (1980) Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol 124:226–231PubMedGoogle Scholar
  18. 18.
    Woo S, Kaplan ID, Roach M, Bagshaw MA (1988) Formula to estimate risk of pelvic lymph node metastasis from the total Gleason score in prostate cancer. J Urol 140:387PubMedGoogle Scholar
  19. 19.
    Byar DP, Corle DK, Veterans Administration Cooperative Urological Research Group (1981) VACURG randomized trial of radical prostatectomy for stage I and II prostate cancer. Urology 28 (Suppl 4):7–11Google Scholar
  20. 20.
    Blackard CE, Doe RP, Mellinger GT (1970) Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer 29:249–258CrossRefGoogle Scholar
  21. 21.
    Lowe BA, Listrom MB (1988) Management of stage A prostate cancer with a high probability of progression. J Urol 140:1345–1347PubMedGoogle Scholar
  22. 22.
    Rangala N, Cox JD, Byhardt RW, Wilson JF, Greenberg M, Da Conceicao AL (1982) Local control and survival after external irradiation for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 8:1909–1914PubMedCrossRefGoogle Scholar
  23. 23.
    Perez CA, Pilepich MV, Zivnuska F (1986) Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 12:523–531PubMedCrossRefGoogle Scholar
  24. 24.
    Rosen E, Cassady JR, Connolly J, Chaffey JT (1985) Radiotherapy for prostate carcinoma. The JCRT experience (1968–1978). II. Factors related to tumor control and complications. Int J Radiat Oncol Biol Phys 11:725–730CrossRefGoogle Scholar
  25. 25.
    Zagars GK, von Eschenbach A-C, Johnson DE, Oswald MJ (1988) The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 14:701–709PubMedCrossRefGoogle Scholar
  26. 26.
    Hanks GE, Diamond JJ, Krall JM, Martz KL, Kramer S (1987) A 10 year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys 13:499–505PubMedCrossRefGoogle Scholar
  27. 27.
    Byar DP and the Veterans Administration Cooperative Urological Research Group (1972) Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment. J Urol 108:908–913PubMedGoogle Scholar
  28. 28.
    Elder JS, Gibbons RP, Correa RJ Jr, Branner GE (1985) Efficacy of radical prostatectomy for stage A2 carcinoma of the prostate. Cancer 56:2151PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • I. D. Kaplan
  • M. A. Bagshaw
  • C. A. Cox
  • R. S. Cox
    • 1
  1. 1.Department of Radiation OncologyStanford University School of MedicineStanfordUSA

Personalised recommendations